Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -5.00 (-2.30%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

8 Sep 2022 07:00

RNS Number : 6801Y
Warpaint London PLC
08 September 2022
Β 

8 September 2022

Β 

Β 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Β 

Trading Update

Β 

Strong trading performance continues and results for the year ending 31 December 2022 now expected to be ahead of market expectations

Β 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, is pleased to announce an update on current trading ahead of the release of the Company's interim results for the six months ended 30 June 2022 on 21 September 2022.

Β 

As outlined in the Company's 'AGM Statement', announced on 27 June 2022, the Group experienced strong trading in the first half of 2022. The Company is pleased to report that this positive momentum has continued since the end of the first half and consequently the results for the year ending 31 December 2022 are now expected to be ahead of market expectations.Β 

Β 

Group sales for the year ending 31 December 2022 are now expected to be at least Β£61 million, with the key pre-Christmas sales period for the Group still to come. The Group's gross product margin remains robust and continues to be at a level in excess of that achieved in 2021. Adjusted profit before tax* for the year ending 31 December 2022 is now expected to be in excess of Β£9 million.

Β 

In addition to the strong operating performance referred to above, the Group expects to potentially further benefit from favourable foreign exchange gains, through its existing hedging arrangements, although the exact quantum will depend on the prevailing exchange rates for the remainder of the year.

Β 

An update on the outlook for the remainder of 2022 will be provided with the release of the interim results for the six months ended 30 June 2022.

Β 

* Adjusted for exceptional costs, amortisation of intangible assets and share based payments. Adjusted numbers are close to the underlying performance of the business which is regularly monitored and measured by management.

Β 

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Β 

Enquiries:

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

Β 

c/o IFC

Β 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Shaun Dobson, Jen Boorer, Alex Bond - Investment Banking

020 7496 3000

Β 

Shore Capital (Joint Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

Β 

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

020 3934 6630

Β 

Β 

Warpaint London plc

Β 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection, Very Vegan, and Chit Chat.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFERAFIDIIF
Date   Source Headline
9th Oct 20247:00 amRNSBLOCK LISTING RETURN
20th Sep 20247:00 amRNSPDMR Dealings and Total Voting Rights
17th Sep 20247:00 amRNSInterim Results
4th Sep 20247:00 amRNSNotice of Results
2nd Aug 20247:00 amRNSHolding(s) in Company
15th Jul 202410:15 amRNSPDMR/PCA Dealing
26th Jun 202411:33 amRNSResult of AGM
26th Jun 20247:00 amRNSAGM Statement
25th Jun 20243:15 pmRNSHolding(s) in Company
12th Jun 20243:47 pmRNSHolding(s) in Company
7th Jun 20247:00 amRNSWarpaint to present Investor Conference
31st May 20247:00 amRNSDirector/PDMR Purchase of Shares
30th May 20242:31 pmRNSPDMR Dealings and Total Voting Rights
23rd May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSCommencement of Trading on OTCQX in the U.S.
9th May 20243:48 pmRNSBlock listing Interim Return
7th May 20245:41 pmRNSHolding(s) in Company
3rd May 202412:50 pmRNSDirector / PDMR Dealings
3rd May 20247:00 amRNSResult of Accelerated Bookbuild in Warpaint
2nd May 20244:45 pmRNSProposed Accelerated Bookbuild in Warpaint
29th Apr 20247:37 amRNSHolding(s) in Company
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.